NRSN Latest Press Releases

-- January 21, 2026 --

NeuroSense Granted U.S. Patent for Treatment of Alzheimer's Disease PRNewswire 8:30 AM

-- January 8, 2026 --

World-Renowned Alzheimer's Expert Prof. Steven Arnold Joins NeuroSense SAB PRNewswire 8:45 AM

-- December 4, 2025 --

NeuroSense to Hold Pre-NDS Meeting with Health Canada in April 2026 PRNewswire 7:30 AM

-- November 24, 2025 --

NeuroSense Receives FDA Clearance to Initiate Pivotal Phase 3 Trial for PrimeC in ALS PRNewswire 9:56 AM

-- November 3, 2025 --

NeuroSense to Host Investor Webinar on December 8, 2025 PRNewswire 9:15 AM

-- October 6, 2025 --

NeuroSense: PrimeC Produces Statistically Significant Reductions in Alzheimer's Disease Biomarkers PRNewswire 9:00 AM

-- September 10, 2025 --

NeuroSense's Drug Candidate Shows Early Signals of Benefit in Alzheimer's Patient-Derived Neurons PRNewswire 2:30 PM

-- September 4, 2025 --

NeuroSense Therapeutics Announces $500,000 Private Placement at Premium to Market Price PRNewswire 8:49 AM

Market Data Delayed 15 Minutes

Questions? Feedback?Olark live chat software